Natural psychedelic drug development company Filament Health (OTCQB: FLHLF) has released its unaudited consolidated, condensed financial results for Q1 2023 ended June 30. Numbers show:
Canadian clinical-stage natural psychedelics company Filament Health (OTCQB: FLHLF) has entered into a definitive agreement with Jupiter Acquisition Corp. (NASDAQ: JAQC), a Special Purpose Acquisition Company (SPAC) for the creation of a